| Stage | R | % of rev | UHAL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.5B | 100.00% | $1.7B | 100.00% | R ×2.05 |
| Gross profit | $702M | 20.35% | $1.7B | 100.00% | UHAL +79.7pp |
| Operating income | $319M | 9.25% | $251M | 14.90% | UHAL +5.7pp |
| Pre-tax income | $226M | 6.55% | $162M | 9.61% | UHAL +3.1pp |
| Net income | $162M | 4.70% | $123M | 7.31% | UHAL +2.6pp |
| Stage | R | UHAL | Gap · A − B |
|---|---|---|---|
| Revenue | $3.5B100.00% | $1.7B100.00% | R ×2.05 |
| Gross profit | 20.35%$702M | 100.00%$1.7B | UHAL +79.7pp |
| Operating income | 9.25%$319M | 14.90%$251M | UHAL +5.7pp |
| Pre-tax income | 6.55%$226M | 9.61%$162M | UHAL +3.1pp |
| Net income |
| 4.70%$162M |
| 7.31%$123M |
| UHAL +2.6pp |
No shared counterparties.